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Abstract.  The metabolism of phosphatidylinositol  (PI) 
and related intermediates  was studied in uninfected 
and Rous sarcoma virus-(RSV) infected chicken em- 
bryo fibroblasts (CEFs).  Cells infected with wild-type 
RSV exhibited twofold increases in steady-state con- 
centrations of inositol trisphosphate  (IP3) and inositol 
bisphosphate (IP2) as compared to uninfected CEFs.  In 
addition,  increased concentrations of IP3 and IP2 were 
observed in CEFs infected with the RSV temperature- 
sensitive transformation  mutant NY72-4 when main- 
tained at the permissive temperature (35°C) for >24 h. 
Slight increases were observed in the amounts of ino- 
sitol lipids in RSV-transformed cells. Phosphoinositol 
metabolic changes were related to transformation  and 
not to viral infection since CEFs infected with NY72- 
4,  maintained at the nonpermissive temperature 
(41.5°C),  revealed amounts of phosphoinositols similar 
to that of uninfected cells. CEFs infected with a 
transformation-defective virus exhibited PI metabolic 
changes intermediate between those of transformed and 
nontransformed cells.  NY72-4 CEF exhibited no in- 
crease in phosphoinositol concentrations before 8 h in- 
cubation at 35°C,  indicating that the transformation- 
specific changes in inositol metabolism were a delayed 
event. Furthermore,  inositol turnover was not activated 
during this time.  In contrast to the case of inositol me- 
tabolism,  significant increases in diacylglycerol (DAG) 
concentrations  were observed within  15-30 min after 
shift of NY72-4 CEFs to 35°C. 
These findings suggest that (a) the major changes in 
inositol metabolism are specific for RSV-transformed 
cells; (b) transformation-specific changes in phos- 
phoinositol content in RSV-infected CEFs are not an 
early effect of the expression of pp60v-s~; and (c) in- 
creases in the DAG content of transformed cells occur 
before changes in inositol metabolism,  indicating that 
DAG may be derived from other lipid sources. 
T 
HE transforming  gene product of Rous sarcoma virus 
(RSV)',  pp60v-s% exhibits  tyrosine-specific  protein 
kinase activity, a property it shares  with a number of 
oncogene products and growth  factor receptors (for review 
see 25). However, the molecular events leading  from tyro- 
sine phosphotransferase  activity  to cellular mitogenesis  re- 
main obscure since phosphorylation of substrates  identified 
appears  to be incidental  (29, 30). 
Attempting  to unravel the steps culminating  in mitogene- 
sis, investigators have concentrated  on the early biochemical 
events  that  follow  proliferative  stimuli.  Recently,  several 
studies have implicated the importance of protein kinase ac- 
tivities  specific to serine/threonine  residues after mitogenic 
stimulation  of cells.  For example,  a ribosomal protein  $6- 
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specific  serine phosphotransferase  has  generated  much in- 
terest since it is one of the earliest responding  enzymatic ac- 
tivities  after cellular stimulation  by several oncogenes and 
growth factors  (9, 22, 28).  However, the link between the 
proliferative  stimuli  including  tyrosine phosphotransferase 
activity and the identity  and transduction  of the mitogenic 
signal responsible for the stimulation  of the $6 kinase activ- 
ity have remained elusive. 
The  components of the phosphatidylinositol  (PI)  meta- 
bolic cycle appear to be signal transducers  used by a number 
of hormones  and  growth  factors  including  c~-adrenergic 
agents  (50),  thyrotopin-releasing  hormone (21, 24),  vaso- 
pressin (11), muscarinic cholinergic  agents  (11), bombesin 
(12),  and  platelet-derived  growth  factor  (6).  Agents  that 
stimulate PI turnover can potentially generate two intracellu- 
lar second messengers;  namely,  diacylglycerol  (DAG) and 
inositol-l,4,5-trisphosphate  (IP3) (3).  DAG in the presence 
of calcium ion can influence the phosphorylation state of a 
number of intracellular  proteins by activating protein kinase 
C (3). Protein kinase C is of particular significance since 12- 
O-tetradecanoylphorbol  13-acetate,  a  known  mitogen  for 
some cells, can activate the kinase by substituting  for its en- 
dogenous effector, DAG (3, 38). Likewise,  IP3 is of interest 
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internal cellular stores after its binding to specific receptors 
(6, 8, 26, 46, 47). Koch and Diringer (33) showed that trans- 
formed ceils exhibit increased PI turnover when compared 
to their nontransformed parent cells. These studies were ex- 
tended to include transformation by RSV as well (19). More 
recently, several investigations have demonstrated that treat- 
ment of quiescent cells with growth factors or serum results 
in rapid changes in PI turnover. Since RSV-transformed cells 
display a number of  properties similar to those of growth fac- 
tor-stimulated cells,  initial investigations concentrated on 
the in vitro activity of key inositol-metabolizing enzymes. 
These  studies  indicated that transformation by  RSV  and 
related oncogenes resulted in elevated PI kinase activity (31, 
36, 48, 49), phospholipase C activity, PI turnover (27), and 
elevation of DAG (51). Although the activities of different 
inositol-metabolizing enzymes were quantified in vitro, few 
data  regarding  the  in  vivo  steady-state concentrations of 
phosphoinositides in RSV-transformed cells were available. 
Furthermore, no data was available  with regard to the tem- 
poral relationship of phosphoinositide metabolism and ex- 
pression of pp60  v-sr~, the transforming protein.  Therefore, 
the quantitation of  phosphatidylinositol metabolic intermedi- 
ates was performed in uninfected and RSV-infected chicken 
embryo fibroblasts (CEFs). 
The data reported below indicate that indeed, transformed 
cells exhibited altered amounts of phosphoinositols when 
compared to their nontransformed counterparts.  However, 
experiments  using  temperature-sensitive,  transformation- 
defective RSV-infected fibroblasts indicated that the change 
in inositol metabolism was a  relatively late event.  In fact, 
nontransforming mutant RSV-infected  CEFs revealed some 
PI metabolite changes that were similar to their transformed 
counterparts.  In contrast, rapid increases in DAG concen- 
tration  were  observed  after  expression  of  pp60  v-src and 
were temporally dissociated from the transformation-spe- 
cific changes in PI metabolism. 
Materials and Methods 
Materials 
Phytic acid was obtained from Sigma Chemical Co. (St. Louis, MO). AG-I- 
X8 anion exchange resin was purchased from Bio-Rad Laboratories, Digilab 
Div.  (Cambridge, MA).  myo-l,2[3H]inositol, [5,6,8,9,11,12,14,15-3H(N)] - 
arachidonic acid and [3H]acetic  anhydride were supplied by New England 
Nuclear (Boston, MA). [32po4] was purchased from ICN Radiochemicals, 
Div.  ICN  Biomedicals Inc.  (Irvine,  CA).  Bovine calf serum was from 
HyClone Laboratories, Sterile Systems, Inc. (Logan, UT) and DME was 
from Gibco Laboratories (Grand Island,  NY).  10-14-d-old chicken em- 
bryos were obtained from SPAFAS,  Inc.  (Norwich,  CT).  RSV mutants 
NY72-4 and NY315 were kind gifts from H. Hanafusa (The Rockefeller 
University, New York).  All other chemicals were reagent grade or better. 
Cell Culture 
Primary CEFs and CEFs infected with a  wild-type RSV (i.e., Schmidt- 
Ruppin strain A [SRA]) or RSV transformation-defective  mutants, NY72-4 
or NY315, were grown at 41.5°C on 100-mm culture dishes (Costar, Cam- 
bridge, MA) using DME supplemented with 5% bovine calf serum as de- 
scribed previously (10).  To assess the progress of viral infection, cellular 
extracts were assayed for their ability to phosphorylate IgG from tumor- 
bearing rabbit serum (39). All experiments used cells that were between the 
fifth and tenth passages and at least tv~ passages after infection with retro- 
virus. 
Cellular Labeling with myo4,2-pH]inositol 
For these experiments, 60-ram culture dishes (Costar) were seeded at either 
0.25 or 1.0  x  llY  i cells per dish in 3 ml inositol-free DME (prepared ac- 
cording to Gibco Laboratories, Grand Island, NY,  but myo-inositol was 
eliminated from the vitamin mixture) supplemented with 5% calf serum. 
After 5 h, 1 ml of inositol-freeDME  containing 5 % calf serum and 5 #Ci/mi 
myo-l,2-[3H]inositol was added to each dish. After 3 d of culture at 41.50C, 
the cells were confluent, and the medium was then replaced with inositol- 
free DME  containing 0.5%  calf serum.  The cells were maintained for 
16-24 h in low serum before initiation of temperature shift or serum stimu- 
lation experiments. Cells could be maintained for at least three passages in 
inositol-free DME with no detrimental effects. To estimate the relative turn- 
over of phosphoinositols in CEFs, some plates of cells were incubated for 
30 rain with l0 mM LiC1 just before cell lysis. Lithium ion prevents inositol 
monophosphate hydrolysis by  inhibiting  phosphomonoesterase (4,  21). 
Hence, changes in inositol monophosphate  concentration after lithium treat- 
ment of cells should reflect the relative activity state of the PI metabolic 
cycle. 
Cellular Labeling with [32P]PO, 
Conditions for labeling with [32p]Po4  were identical to those described 
above for inositol labeling except that unmodified DME and  10 #Ci/ml 
[32PlPO4 was used in place of inositol-free DME and [3H]inositol,  respec- 
tively. 
Synthesis of myo-P2Plinositol-l,4,5-trisphosphate 
Preparation of myo-[a2p]inositol-l,4,5-trisphosphate  was essentially as de- 
scribed by Dowries et al. (20). After the release of inositol phosphates from 
erythrocyte membranes with Ca  2+,  the  resulting supernatant was chro- 
matographed on AG-1-X8-formate columns, and desalted by lyophilization 
(16). Thin layer electrophoresis on cellulose sheets in 100 mM sodium oxa- 
late, pH 1.5, showed that the radiolabeled compound migrated with authen- 
tic IP3 generated by partial acid hydrolysis of phytic acid. Contamination 
with [32p]PO4 never exceeded 5% of the total radioactivity. 
Hydrolysis of  Phytic Acid 
Partial acid hydrolysis of phytate can generate inositol phosphates contain- 
ing  1-5  mol PO4/mol of inositol (44).  (It should be noted that inositol 
phosphates generated in this way contain mixed forms of IP, IP2, IP3, IP4, 
and IP5 [e.g., inositol-l-monophosphate, inositol-2-monophosphate, etc.]. 
Hence, it is assumed that enhanced recovery occurs for all classes of phos- 
phoinositols, exclusive of their form.) The method of Desjobert and Petek 
(18) was used to hydrolyze phytic acid, and this phytate hydrolysate was then 
used as carrier to aid in the recovery radiolabeled inositol phosphates. As 
previously shown (44) and confirmed by thin layer electrophoresis, when 
40%  of the phytic acid was completely hydrolyzed to PO4,  '~15-20%  of 
the original phytate was converted to an inositol species containing three 
phosphates. 
Quantitation of  lnositol Metabolites 
Measurement of Water-soluble Inositol Phosphates. After temperature 
shift or incubation with serum, experiments were terminated by the addition 
of 0.75 ml of ice cold 5% (wt/vol) TCA. Before scraping the cells from the 
plates, 200 ttl of phytate hydrolysate (i.e., corresponding to '~0.4 #mol of 
IP3-1ike inositol) containing 2,000-3,000  dpm of [32p]IP3 was added to 
each plate. The TCA/cell mixtures were transferred to 1.5 ml conical poly- 
propylene tubes and centrifuged for 5 min at high speed in a microcen- 
trifuge. The soluble extract was transferred to a test tube and the cells were 
washed once more with 0.5 ml 5 % TCA. The aqueous layers were combined 
and the TCA was removed by five extractions with 4 vol of diethyl ether. 
The aqueous samples were applied to AG-1-X8-formate columns to separate 
the water-soluble phosphoinositols as described previously (5). Radioactiv- 
ity in the column eluates was analyzed by dual channel liquid scintillation 
spectrometry and corrected for radioisotope channel spillover and for recov- 
ery of [32p]IP3. The cellular precipitates were stored at  -20°C until ana- 
lyzed for lipid inositol. 
Measurement of  Lipid Inositols. The lipid inositols were extracted from 
cell  precipitates  with  2  ml  of  chloroform/methanol/concentrated HCI 
(200:100:1,  by volume).  The  lipids  were deacylated to their  respective 
glycerophospho-derivatives  with monomethylamine (15), and separated by 
anion exchange chromatography as described by Berridge (2). 
The Journal  of Cell Biology,  Volume 108, 1989  684 3  pH]Arachidonic Acid Labeling of  Neutral Lipids 
Uninfected and NY72-4-infected CEF were labeled for 4 h at 41.5°C with  "[- 
0.5  /~Ci/ml  [3H]arachidonic  acid  in  DME  containing  10%  delipidated 
BSA. The cells were washed twice with PBS and incubated for another hour  ~_  2 
with DME at 41.5°C.  The cells were then incubated at 35°C for the indi- 
cated times before lipid extraction. To augment identification by iodine va- 
por, authentic neutral lipid standards were added to each sample just before  ~  1 
separation by TLC (45). Spots corresponding to mono-, di-, and triglycer-  __. 
ides were scraped from the plates and analyzed with a liquid scintillation  __q 
counter.  ~  o 
Measurement of  DAG 
DAG was measured by the method of Banschbach et al. (1) as altered by 
Farese et al. (23) with slight modifications. Briefly, the 1,2-DAG from each 
culture dish was purified and separated from 1,3-DAG by TLC (45)  and 
quantitatively  acetylated with [3H]acetic anhydride.  The acetylated [3H]DAG 
was then rechromatographed on thin layer plates and quantitated by liquid 
scintillation spectrometry. With this procedure, DAG-associated radioactiv- 
ity is directly proportional to the total mass of the lipid. 
Measurement of  Phosphatidic Acid (PA  ) 
Lipids were extracted as described above for lipid inositols. Phospholipids 
were separated by TLC (45) and [32p]PA was located by co-migration of 
autoradiographic  spots with authentic unlabeled PA.  The  [32p]PA spots 
were scraped into vials and analyzed for [32p] radioactivity. 
Miscellaneous Procedures 
Phosphate was measured using the method of Lanzetta et al. (35). BSA was 
rendered free of fatty acids by the method of Chen (14). In experiments with 
radiolabeled cells, after organic extraction of lipid, the remaining protein 
was very difficult to solubilize and quantify. Therefore, cells were released 
from parallel  culture dishes by trypsin and quantitated using a  Coulter 
counter (Coulter Electronics Inc., Hialeah, FL). All data, unless specified 
otherwise, were expressed per 106 cells. 
Results 
Phasphoinositol Metabolism 
Effects of Viral Infection~Transformation  on PI Metabo- 
lism. To examine alterations in PI metabolism in response to 
transformation or viral infection, phosphoinositols and poly- 
phosphoinositides were analyzed from [3H]inositol-labeled 
CEFs.  Preliminary experiments indicated that  [3H]inositol 
uptake by CEFs was relatively slow with steady-state labeling 
of PI being attained at ~48 h. Hence, cells were cultured in 
the presence of [3H]inositol for 48-72  h.  Initially  [32p]IP3 
was included in each sample analyzed, but there was sig- 
nificant variability in recovery of 32p. Partially hydrolyzed 
phytic acid was tested and was found to be a more suitable 
carrier for recovery of phosphoinositols. After the inclusion 
of phytate hydrolysate in all samples, smaller fluctuations in 
the recovery of [32p]IP3 were observed. 
Fig.  1 and Table I show the amounts of phosphoinositols 
in  uninfected  cells  or  CEFs  infected  with  either  NY315, 
NY72-4, or wild-type SRA. To determine the relative turn- 
over of the PI cycle intermediates, [3H]inositol-labeled cells 
were incubated for 30 min in the presence or absence of 10 
mM LiCI before cell extraction. The data in Fig. 1 show that 
SRA-transformed CEFs and NY72-4-infected CEFs main- 
tained at 35°C, a temperature permissive for transformation, 
had greater amounts of IP in the presence of Li  ÷ ion than in 
its absence. Correspondingly, the ratio of IP concentration 
in the presence and absence of Li  ÷ ion was much less for 
[Z3 41.5"C 
E;~ 35.0"C 
UN  315  72-4  SRA 
Figure 1.  PI turnover in uninfected and SRA-infected CEFs.  The 
conditions for cell manipulation were identical to those described 
in Table I. However, half of the plates were made 10 mM LiC1 30 
min before analysis to evaluate PI turnover. The bars show the ratio 
of IP concentration  in the  presence  and absence  of Li  ÷ ion and 
error bars represent the SEM. UN, uninfected CEFs. 315, 72-4, and 
SRA, CEFs  infected  with  NY315, NY72-4,  and  SRA  viruses, 
respectively. 
NY72-4-infected CEFs maintained at 41.5°C or uninfected 
CEFs.  Table  I  demonstrates  that  RSV-transformed  CEFs 
maintained higher steady-state concentrations of IP3 and IP2 
than uninfected CEFs.  Approximately 1.5-2-fold increases 
in IP3 concentrations were observed in cells transformed by 
SRA or NY72-4. However, the data show also that NY315- 
infected CEFs exhibit phosphoinositol concentrations some- 
what similar to those of transformed CEFs. Although NY315 
virus is not transforming, PI turnover was slightly elevated 
and IP2/IP3 concentrations  were similar to those observed 
in transformed cells. 
As shown in Table II, differences were observed in PI and 
the polyphosphoinositides as well.  SRA-transformed cells 
differed  in  the  amount  phosphatidylinositol  bisphosphate 
PIP2  from  uninfected  or  temperature  conditional  NY72- 
4-infected CEFs maintained at 41.5°C.  Similarly, NY72-4- 
infected CEFs maintained at 35°C showed increased amounts 
of phosphatidylinositol monophosphate  (PIP)  and  PIP2  as 
Table L  Polyphosphoinositol Levels in Uninfected and 
RSV-infected CEF 
Percent total inositol 
Cells  Temperature  IP2  IP3 
Uninfected  41.5°C  0.085 (0.003)  0.183 (0.004) 
35°C  0.080 (0.003)  0.189 (0.012) 
NY315  41.5°C  0.116 (0.005)  0.290 (0.034) 
35°C  0.132 (0.004)  0.350 (0.022) 
NY72-4  41.5°C  0.069 (0.001)  0.176 (0.026) 
35°C  0.190 (0.003)  0.300 (0.010) 
SRA  41.5°C  0.130 (0.003)  0.280 (0.022) 
35°C  0.150 (0.013)  0.380 (0.103) 
Cells were maintained at either 41.5°C or 35°C and incubated with [3H]ino- 
sitol as described in Materials and Methods. After a 24-h incubation in inositol- 
free DME containing 0.5% serum, the cells were washed, lysed, and analyzed 
for inositol content. Parallel cultures  indicated that cell numbers ranged from 
1.3 to  1.8  x  106 cells/60-mm dish. The data are expressed as the average 
percent of total inositol for triplicate plates and values in parentheses are SEM. 
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RSV-infected CEF 
Percent lipid inositol 
Cells  Temperature  PI  PIP  PIP2 
Uninfected  41.5°C  91.65  (8.17)  5.08  (1.31)  3.27  (0.55) 
35°C  91.78  (4.97)  4.97  (0.70)  3.25  (0.43) 
NY315  41.5°C  92.27  (6.17)  4.70  (0.61)  3.03  (0.23) 
35°C  91.39  (5.83)  5.43 (0.28)  3.18 (0.53) 
NY72-4  41.5°C  92.54  (1.80)  4.33  0.33)  3.13  (0.33) 
35°C  90.42  (2.50)  5.98  (0.46)  3.60  (0,49) 
SRA  41.5°C  91.24  (1.40)  5.09  (0.19)  3.66  (0.32) 
35°C  91.04 (2.92)  5.14 (0.44)  3.83 (0.76) 
Conditions for cell labeling and inositol determinations were as described in 
Table I.  Data are expressed as the average percent of total lipid inositol for 
triplicate determinations and values within parentheses represent SEM. 
compared to uninfected CEFs. When contrasted to morpho- 
logically normal ceils, CEFs transformed by SRA and NY72- 
4 viruses exhibited  10-25% increases in PIP and PIP2. Lit- 
tie differences were observed in the amounts of PI present 
in  these  cells.  Although  NY315-infected  CEFs  exhibited 
elevated phosphoinositol concentrations, the pattern of poly- 
phosphoinositides resembled  that of uninfected cells. 
Effect of pp60  ~'~ Expression on PI Metabolite Concen- 
tration. To investigate the relationship between the expres- 
sion  of pp60  V-s~ activity  and  the  onset  of changes  in  PI 
metabolism,  temperature-sensitive  transformation  mutant 
NY72-4-infected CEF were used. After [3H]inositol  labeling, 
NY72-4-infected  CEFs  maintained  at  41.5°C  were  made 
quiescent with serum deprivation.  The data in Figs.  2  and 
3  were obtained  from cells  shifted  for the indicated times 
from 41.5°C to 35°C before quantitation of inositol metabo- 
lites as described in Materials and Methods. Duplicate plates 
of NY72-4-infected CEF cells were tested for pp60  V-s~ ac- 
tivity as well.  As shown, there were slight to no changes in 
the steady-state concentrations of many of the inositol metab- 
olites before eight hours of incubation at the permissive tem- 
perature.  The only exception was an increase in polyphos- 
phoinositides that occurred between 5 and 8 h after tempera- 
ture shift (Fig. 3).  However, as shown in Figs. 2 and 3 and 
as indicated previously in Tables I and II, major changes in 
PI metabolism were observed only after a 24-h incubation 
at 35°C. Furthermore,  these changes in PI metabolism oc- 
curred many hours after the expression of immunoglobulin 
phosphotransferase  activity  specific  for pp60  V-src. This  de- 
layed response in PI metabolism could not be attributed to 
cell density since equivalent results were obtained from cells 
examined at fivefold lower density. No significant change in 
[3H]inositol metabolites were observed in uninfected CEFs 
after temperature shift (Tables I and II and data not shown). 
Effects of Serum on PI Metabolism.  The response of PI 
metabolism to serum stimulation was examined in quiescent 
serum-starved uninfected and NY72-4-infected CEFs main- 
tained at 41.5°C.  Fig. 4  demonstrates that IP2 and IP3 con- 
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Figure 2. Effect of temperature  on phosphoinositol  con- 
centration  in  NY72-4-infected CEFs.  (a  and b)  Cells 
were  seeded  at  106 cells/60-mm plate  in  inositol-free 
DME containing  5% calf serum and 5 #Ci/ml myo-l,2- 
[3H]inositol as described in Materials  and Methods.  Af- 
ter 3 d of culture,  the medium was changed to inositol- 
free DME containing 0.5 % calf serum, and the cells were 
maintained  for 24 h at 41.5°C.  After a shift to 35°C for 
0, 0.01, 0.05, 0.12, 0.25, 0.5, 1, 2, 4.5, 8, and 24 h the cells 
were analyzed for inositol metabolites.  At the conclusion 
of the experiment,  the cell number was determined to 
range from 2.5 to 3 ×  106 cells per dish. The data are ex- 
pressed as means + SEM of  triplicate determinations.  (a) 
IP concentration in cells incubated  in the absence (o) or 
presence (o) of 10 mM LiC1. (b) [] and •  represent  IP2 
and IP3 concentrations,  respectively.  (c) IgG kinase  ac- 
tivity from NY72-4-infected CEF extracts after incubat- 
ing cells  at 35°C for 0, 0.083, 0.25, 0.5,  1, 2, 4, 8, and 
24 h. Data are expressed  as the percent of maximum ob- 
served  after 24 h at the permissive  temperature. 
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Figure 3. Effect of temperature on lipid inositol concen- 
tration in NY72-4-infected CEFs. The conditions for this 
experiment were identical to those described in Fig. 2. 
Lipid inositol was analyzed as described in Materials and 
Methods.  (a)  PI  concentration  (o).  (b)  PIP  and  PIP2 
concentrations are represented by •  and A, respectively. 
All data are expressed as means +  SEM of triplicate de- 
terminations. 
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Figure 4. Effect of serum on phosphoinositol concentra- 
tion in uninfected and NY72-4-infected CEE Uninfected 
and NY72-4-infected CEFs were maintained at 41.5°C 
and  labeled with [3H]inositol as described in Materials 
and Methods. After 24-h incubation in inositol-free DME 
containing 0.5%  calf serum,  calf serum was added to a 
final concentration of 10%  and the cells were incubated 
from 0 to 10 min as indicated. The data are expressed as 
a percent of the total inositol and error bars represent the 
range of duplicate determinations.  (a-c) Concentrations 
of IP,  11)2, and IP3,  respectively. (o)  Uninfected CEFs; 
(o) NY72-4-infected CEFs. 
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response  to  mitogenic  amounts  of calf serum.  However, 
NY72-4-infected  CEF  and  uninfected  CEFs  did  exhibit 
differences in the relative amounts of individual  phospho- 
inositols.  NY72-4-infected CEF showed a more rapid but 
less intense increase in IP2 concentrations after the addition 
of serum. In contrast, uninfected CEFs exhibited an immedi- 
ate increase in IP3 followed by a  more gradual increase in 
IP2 in response to serum. 
DAG and PA Metabolism 
The effect of pp60  ..... expression on incorporation of [aH]- 
arachidonic acid into neutral lipids was examined in NY72- 
4-infected CEFs. The data in Fig. 5 indicates that a shift in 
incubation temperature from 41.5°C to 35°C did not alter the 
incorporation of [3H]arachidonate into mono-, di-, and tri- 
glycerides of uninfected CEFs nor mono- and triglycerides 
of NY72-4-infected CEFs. However, NY72-4-infected CEFs 
exhibited  approximately  twofold  increases  in  [3H]arachi- 
donate-labeled DAG after a  shift of cells to the permissive 
temperature for 2 h. Detectable increases in [3H]DAG were 
observed when cells were incubated at the permissive tem- 
perature for 1 h. 
Since [3H]arachidonate labeling of DAG reflects a combi- 
nation of increased relative mass and precursor incorporation 
of the lipid, an alternative procedure was used to assess the 
temperature-induced changes in total mass of DAG alone. In 
Fig.  6 a,  radioactivity is directly proportional to the total 
mass of DAG in cells since the lipid was quantitatively iso- 
lated and acetylated with  [3H]acetic anhydride.  A  shift of 
incubation temperature from 41.5°C to 35°C rapidly altered 
total DAG content of NY72-4-infected CEFs with no corre- 
sponding change in DAG content of uninfected CEFs.  This 
increase in DAG occurred much earlier than the correspond- 
ing changes in phosphoinositol content shown above. Since 
DAG changes were not accompanied by changes in PI turn- 
over, it was presumed that sources other than phosphoinosi- 
tides exist for DAG.  Recently, other studies have suggested 
that noninositide lipids may act as sources for DAG (23,  32, 
34, 37). One purported source for DAG is PA. Consequently, 
NY72-4-infected  or uninfected  CEF cells were incubated 
with [32po4] for 3 d to label PA to near equilibrium and the 
content of PA was analyzed. The data in Fig. 6 b indicate that 
after the  expression of pp60  .....  a  1.5-2.0-fold  increase  in 
total cellular PA was observed at the permissive temperature. 
The increase in total PA occurred after the change in DAG 
content of the transformed cells. 
Discussion 
Numerous studies have implicated the potential role of sec- 
ond messenger systems in mitogenesis and proliferation of 
cells in culture  (for review see 41). Prior work with cells 
transformed by RSV indicated altered PI metabolism when 
compared  to  uninfected  cells.  To  thoroughly  define  the 
changes  in  PI  metabolism  caused  by  the  expression  of 
pp60v-s% phosphoinositols and related lipid metabolites were 
examined  in  mutant  RSV-infected  CEFs.  Although  the 
findings were generally consistent with previous studies, our 
use of temperature defective mutants of RSV indicated that 
the pp60  ..... induced alterations in PI metabolism were tem- 
porally dissociated from DAG metabolism. 
The  use  of  transformation-defective  mutants  revealed 
some unexpected changes in the steady-state concentrations 
of the  inositol  metabolites.  For  example,  NY315-infected 
CEFs  are transformation negative by virtue of an  amino- 
terminal deletion of 15 amino acids in pp60  V-src that results 
in its corresponding lack of both myristylation and associa- 
tion  with  the  plasma  membrane  (17).  In  vivo  tyrosine- 
specific  phosphotransferase  activity  and  phosphotyrosine 
content varies little in cells expressing either wild-type or 
amino-terminal mutants of pp60  ..... (17, 30). Although some 
aspects of PI metabolism in  NY315-infected CEFs appear 
similar to those of uninfected CEFs,  the amounts of phos- 
phoinositols  were  comparable to  concentrations  found  in 
transformed  CEFs.  These  data  suggest  that  the  pp60  ...... 
I-- 
z  200  i,i 
o  m,, 
i,i 
~-  150  v 
z 
LI.i 
I-- 
0  100 
oc 
o_ 
(.D 
:E  50 
o  0 
T 
l 
T 
T  0 
I  I  I  I  I  I  I  I  I 
0  1  2  3  4 
TIME  (HOURS) 
Figure 5.  Effect of tempera- 
ture  on  [3H]arachidonic acid 
labeling  of neutral  lipids  in 
uninfected  and  NY72-4-in- 
fected CEE Cells were seeded 
at ,o106 cells/60-mm dish and 
cultured  at  41.5°C for  3  d. 
Cells were labeled for 4 h with 
[3H]arachidonic  acid  before 
incubation for O, 1, 2, and 4 h 
at 35°C. Data were expressed 
as a percent of total [3H]cpm/ 
mg protein obtained at 41.5°C. 
(A-zx) Monoglyceride;  (o-o) 
diglyceride;  (m-[]) triglycer- 
ide; open symbols, NY72-4- 
infected  CEFs;  closed  sym- 
bols, uninfected CEFs. 
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Figure 6.  Effect of tem ~erature on DAG and PA metabolism. (a) 
DAG; NY72-4-infected CEFs or uninfected CEFs were seeded at 
106 cells/60-mm dish and cultured at 41.5°C for 3 d. The media 
was exchanged with DME containing 0.5 % calf serum and incuba- 
tion continued for 24 h. After the shift of temperature from 41.5°C 
to 35°C for the indicated times, neutral lipids were extracted from 
cells, and DAG was analyzed as described in Materials and Meth- 
ods. The data are expressed as the mean of triplicate dishes and er- 
ror bars represent SEM. Cell density, as determined from parallel 
cultures, reached 3 x  106 cells per dish. Open and closed circles 
represent uninfected and NY72-4-infected CEFs, respectively. (b) 
PA, NY72-4-infected CEF were seeded at 0.7 x  106 cells/60-mm 
dish and were cultured at 41.5°C in DME containing 5 % calf serum 
and 10 #Ci/ml [32po4]. 3 d later, the medium was exchanged with 
DME containing 0.5 % serum and 10 #Ci/ml  [32po4]. After 24-h 
incubation, the cells were incubated at 35°C for the times indicated 
and analyzed for [32p]PA as described in Materials and Methods. 
The data are expressed as the means :i: SEM for triplicate plates 
of cells. Cell density at the time of analysis reached ,04.5  ×  106 
cells per plate. 
associated increase in phosphorylated inositol metabolites 
resembles an analogous increase in tyrosine phosphorylation 
of  other adventitious substrates (30). Therefore, it is unlikely 
an increase in phosphoinositols by themselves is sufficient to 
transform CEFs.  However, the data presented here are not 
inconsistent with a potential role for increased phosphoino- 
sitols in the greater saturation density and growth rates ob- 
served for cells infected by RSV-expressing pp60~-s~s mu- 
tated at the amino terminus (13, 30). 
The use of temperature-sensitive transformation-defective 
mutants of RSV allows for the rapid expression of pp60  ..... 
activity in infected cells after a shift to a permissive, lower 
temperature. These viral mutants proved useful in delineat- 
ing some of the early biochemical events after expression of 
pp60  ..... activity that eventually culminate in cellular trans- 
formation of cells maintained at the permissive temperature 
(for review see 29, 52). In this study, temperature-sensitive 
transformation-defective NY72-4-infected CEFs were used 
to examine the dependence of PI metabolism on expression 
of pp60  v-src activity. As predicted from previous studies, PI 
metabolism resembled that of uninfected CEFs when NY72- 
4-infected CEFs were cultured at the nonpermissive temper- 
ature.  NY72-4-infected CEFs,  cultured  at  a  temperature 
permissive for transformation, resembled SRA transformed 
CEFs in both PI turnover and steady-state concentrations of 
inositol intermediates.  However, temperature shift experi- 
ments indicate that these PI metabolic changes occur with a 
timecourse different from that of many other enzymatic pro- 
cesses known to be influenced by the expression of pp60  ~-s~. 
Activation  of 2-deoxyglucose uptake,  sodium/proton  ex- 
change, and ribosomal protein $6 phosphorylation are exam- 
pies of processes that change before that of PI metabolism 
in these cells. The sluggish responsiveness of PI metabolism 
to temperature shift was not a general property of CEFs nor 
RSV-infected cells since they respond rapidly to mitogenic 
serum concentrations. Thus we conclude it is unlikely that 
RSV-stimulated increase in inositol phosphate metabolism 
provides an early trigger leading to CEF proliferation and 
transformation in culture. 
Our initial impressions of the data obtained with RSV mu- 
tants seemed to contradict previous findings (27, 31, 36, 48, 
49). However, the previous studies using cells transformed 
by oncogenes that encode or influence tyrosine kinases failed 
to examine the temporal relationship of phosphoinositol con- 
centration with expression of  the transforming factors. In this 
study, we report the actual changes in PI metabolite concen- 
trations as opposed to the potential for change as measured 
in studies that solely examine in vitro enzymatic activity. 
Nevertheless, our data do support prior studies that analyzed 
PI metabolism in cells constitutively expressing oncogenes. 
Furthermore, data presented in this manuscript expand upon 
previous findings by dissociating  early events  of pp60  v-,~ 
expression from PI metabolism. Thus it would appear that 
changes in steady-state PI metabolite concentrations, though 
tightly associated with the transformed state, probably reflect 
a cellular response to transformation and growth as opposed 
to a direct causal relationship.  In fact, dissociation of the 
mitogenic effect  of  growth-promoting agents from phosphati- 
dylinositol metabolism has been shown previously (7). 
The diesteratic breakdown of phosphoinositides by phos- 
pholipase C generates DAG.  Since NY72-4-infected CEFs 
exhibited slow changes in inositol metabolism on shift to the 
permissive temperature, it was presumed that DAG concen- 
trations  would  increase  in  like  manner.  Although  trans- 
formed cells were recently shown to exhibit higher levels of 
DAG than their nontransformed parental cells (34, 51), the 
temporal  relationships  between  oncogene expression and 
changes in DAG were not determined. Our studies show that 
temporally, pp60  .....  induced changes in PI metabolism can 
be dissociated from DAG metabolism. When the tempera- 
ture of NY72-4-infected CEF was shifted from 41.5°C to 
35°C, total DAG increased twofold within 30 min and began 
to plateau •2  h later. This change in DAG was not a tempera- 
ture-induced,  nonspecific effect since other neutral  lipids 
failed to show any change, and the increase in DAG was spe- 
cific for cells expressing pp60  v-s~. Furthermore, the change 
in DAG precedes any major alteration in PI turnover and 
would imply that phosphoinositides are not the source of 
DAG for this increase. 
Saltiel et al.  (43)  reported that insulin-stimulated  DAG 
production resulted in part from the breakdown of a novel 
PI glycan. In our studies, the water-soluble product of phos- 
pholipase C-catalyzed cleavage of any presumed PI glycan 
would comigrate with other labeled inositols in the glycero- 
phosphoinositol fraction.  We were unable to reproducibly 
observe changes in this inositol-containing fraction (data not 
shown), and therefore PI glycan was ruled out as a viable 
source for DAG.  Furthermore, DAG accumulations deter- 
mined  from  [3H]arachidonate-labeled  cells  confirm  this 
finding since myristate is the major fatty acid constituent of 
this novel PI glycan (43). Farese et al. (23) reported that in- 
sulin treatment of myocytes and rat adipocytes generates PA 
and DAG with little to no change in PI metabolism. These 
studies prompted our investigation into the likelihood that 
dephosphorylation of newly accumulated PA could act as a 
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was an unlikely source for DAG in our system since increases 
in this phospholipid occurred subsequent to any increase in 
DAG  concentration.  Moreover,  increases  in  PA  probably 
represent  enhanced DAG phosphorylation that is consistent 
with the increase availability  of substrate and the reported in- 
crease  in  DAG  kinase  activity  (48).  Recently,  Harvey ~- 
transformed  cells  were shown to  have  higher  amounts  of 
DAG than their nontransformed  parental cells (34). This ac- 
cumulation of DAG was accompanied by an increase in the 
turnover  of phosphatidylcholine  and phosphatidylethanol- 
amine but  not  in phosphatidylinositol,  thereby  suggesting 
that these phospholipids were the putative  source. More re- 
cently, interleukin-1  treatment of T lymphocytes was shown 
to stimulate rapid DAG and phosphocholine production with 
no change in PI metabolism nor intracellular  calcium con- 
ce'ntrations (40). Moreover, tumor-promoting phorbol esters 
and bombesin were shown to increase phospholipase C-cat- 
alyzed hydrolysis of phosphatidylcholine in [3H]choline-la- 
beled Swiss 3T3 cells (37). However, preliminary experiments 
(Martins, T. J., and R. L. Erikson, unpublished observations) 
indicate  that  phosphocholine  release  in  NY72-4-infected 
CEFs remained similar to that in uninfected CEFs regardless 
of the incubation temperature.  Since more thorough analyses 
of DAG molecular species indicate that the majority of DAG 
synthesized during thrombin stimulation of rat mast cells was 
not derived from PI metabolism  (32),  future  experiments 
must investigate  the possibility that RSV-associated  changes 
in DAG metabolism occur at the expense of other phospho- 
lipids. It is also important  to note that despite the early in- 
crease in DAG observed in these studies, there is little data 
regarding  early activation  and redistribution  of protein ki- 
nase C  in RSV-transformed  fibroblast.  Although Wolfman 
et  al.  (51) indicated  that  stably  transformed  RSV-infected 
3T3 cells exhibited down regulation of both protein kinase 
C and its major 80-kD substrate, another study demonstrated 
apparent  activation  of protein kinase C  and  increased  80- 
kD phosphorylation  in CEFs  after transient  expression of 
pp60  v-s~ (42).  Thus, these important proximal  events require 
additional  attention. 
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